✦ LIBER ✦

Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast Cancer

✍ Scribed by Eleni Andreopoulou; Darci Gaiotti; Eugene Kim; Matthew Volm; Ruth Oratz; Robin Freedberg; Andrea Downey; Charles L. Vogel; Stephen Chia; Franco Muggia

Book ID: 115075746
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 105 KB
Volume: 7
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2007.n.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of trastuzumab plus

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

✍ Tomo Osako; Yoshinori Ito; Shunji Takahashi; Nahomi Tokudome; Takuji Iwase; Kiyo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

Safety and efficacy of metronomic non-pe

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients

✍ L. Manso, N. Valdiviezo, J. Sepúlveda, E. Ciruelos… 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 158 KB

5076 POSTER Phase II Study of Vinorelbin

5076 POSTER Phase II Study of Vinorelbine Plus Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines and Taxanes

✍ Kwon, H.; Oh, S.Y.; Kim, S.H.; Lee, S.; Lee, J.H.; Kim, H.J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Phase II trial of pegylated liposomal do

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

✍ Antonio C. Wolff; Molin Wang; Hailun Li; Michael R. Pins; Florence J. Pretorius; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 311 KB

Role of HER3 expression and PTEN loss in

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

✍ Esteva, F.J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 318 KB

5068 Cardiac safety of non-pegylated lip

5068 Cardiac safety of non-pegylated liposomal doxorubicin in combination with docetaxel as 1st line treatment in locally advanced or metastatic HER2 negative breast cancer (MYOTAX study)

✍ L.J.C. van Warmerdam; P.P. Schiphorst; P. Nieboer; M.W. Dercksen; J.F.M. Pruijt; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB